益生菌在人类营养中的市场规模、份额和成长分析（按类型、应用和地区划分）—2026-2033年产业预测

预计到 2024 年，全球人类营养益生菌市场规模将达到 671.9 亿美元，到 2025 年将成长至 722.3 亿美元，到 2033 年将成长至 1,288.1 亿美元，预测期（2026-2033 年）的复合年增长率为 7.5%。

全球益生菌市场在人类营养领域正经历显着成长，这主要得益于消费者对天然成分产品的日益偏好以及对预防医学的关注度不断提高。中国、日本和印度等主要地区对益生菌的需求特别强劲，促使主要企业加强研发力度，开发更先进的益生菌菌株。递送机制的创新进一步提升了益生菌的功效，造福人类和动物健康。此外，受人口老化和消费者健康意识增强的推动，美国等富裕市场对含益生菌膳食补充剂的需求也呈现激增趋势。这些趋势预示着益生菌产业在不久的将来将保持强劲的成长动能。

推动全球益生菌市场在人类营养领域发展的因素

随着消费者越来越重视维持健康的生活方式，天然食品日益受到消费者的青睐，全球益生菌市场也因此受到显着影响。这种对健康和营养意识的提升，推动了益生菌产品需求的成长，因为越来越多的人将健康放在首位。随着消化器官系统对定期摄取益生菌的各种健康益处（例如改善消化系统健康、减少卡路里摄取、增强免疫力和促进钙吸收）的了解加深，益生菌原料市场在人们以自然方式改善健康的共同愿望的驱动下，持续扩张。

限制全球人类营养益生菌市场的因素

全球益生菌市场在人类营养领域面临许多挑战，其中研发活动需要大量投资，包括建立实验室、购买研究设备和招募专业人才。儘管益生菌的健康益处已得到科学检验，这为市场成长提供了支撑，但製造商往往难以从这些巨额前期投入中获得令人满意的回报。高成本会阻碍新进入者，并限制现有企业的扩张机会，从而形成扼杀创新、阻碍成长潜力的环境。因此，如何在研发支出和盈利能力之间取得平衡，仍然是这个快速成长市场中相关人员面临的关键挑战。

全球益生菌市场趋势及其在人类营养领域的作用

全球益生菌市场在人类营养领域呈现强劲的创新和多元化趋势，製造商纷纷在其产品线中添加各种益生菌产品形式，包括片剂、滴剂和胶囊，以满足特定的健康需求。随着消费者对肠道健康与整体健康之间联繫的认识不断提高，自有品牌和知名品牌公司都在积极推出含有专有益生菌菌株的新型配方。这一成长趋势的驱动力源于消费者对个人化营养解决方案日益增长的需求，从而为膳食补充剂领域一个以功效和消费者选择为优先的充满活力的市场奠定了基础。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 专利分析

全球益生菌在人类营养领域的市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 乳酸菌
• 双叉桿菌
• 酿酒酵母
• 链球菌
• 肠球菌
• 大肠桿菌
• 芽孢桿菌

全球益生菌在人类营养领域的市场规模（按应用和复合年增长率划分）（2026-2033 年）

• 营养补充品
• 功能营养
• 运动营养
• 婴幼儿营养产品
• 其他用途

全球益生菌在人类营养领域的市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Danone SA（France）
• Yakult Honsha Co., Ltd.（Japan）
• Nestle SA（Switzerland）
• Chr. Hansen Holding A/S（Denmark）
• International Flavors & Fragrances Inc.（IFF）（USA）
• Archer Daniels Midland Company（ADM）（USA）
• Probi AB（Sweden）
• BioGaia AB（Sweden）
• Morinaga Milk Industry Co., Ltd.（Japan）
• Lifeway Foods, Inc.（USA）
• General Mills, Inc.（USA）
• PepsiCo, Inc.（USA）
• Kerry Group plc（Ireland）
• Lallemand Inc.（Canada）
• UAS Laboratories LLC（USA）
• Winclove Probiotics BV（Netherlands）
• DSM-Firmenich（Netherlands/Switzerland）
• Sabinsa Corporation（USA）
• Protexin（UK）（part of ADM）
• Bifodan A/S（Denmark）

结论与建议

Global Probiotics In Human Nutrition Market size was valued at USD 67.19 Billion in 2024 and is poised to grow from USD 72.23 Billion in 2025 to USD 128.81 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global probiotics market in human nutrition is experiencing significant growth, driven by a rising preference for natural ingredient-based products and a heightened focus on preventive healthcare. Demand for probiotics is particularly robust in key regions, including China, Japan, and India, where major companies are intensifying research and development efforts to create advanced probiotic strains. Innovations in delivery mechanisms further enhance the effectiveness of probiotics, benefiting both human and animal health. Additionally, affluent markets, such as the United States, are witnessing a surge in the consumption of probiotic dietary supplements, spurred by an aging population and increased consumer awareness regarding health and wellness. These trends indicate a strong growth trajectory for the probiotics sector in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Probiotics In Human Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Probiotics In Human Nutrition Market Segments Analysis

Global Probiotics In Human Nutrition Market is segmented by Type, Application and region. Based on Type, the market is segmented into Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, Escherichia and Bacillus. Based on Application, the market is segmented into Dietary Supplements, Functional Nutrition,Sports Nutrition,Infant Nutritionand other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Probiotics In Human Nutrition Market

The Global Probiotics in Human Nutrition market is significantly influenced by the growing popularity of natural food products as consumers increasingly recognize the importance of maintaining a healthy lifestyle. This heightened awareness surrounding health and nutrition has sparked increased demand for probiotic offerings, with many individuals prioritizing their personal well-being. As consumers become more informed about the various health benefits associated with the regular consumption of probiotics-such as enhanced digestive health, reduced caloric intake, improved immunity, and better calcium absorption-the market for probiotic ingredients continues to expand, driven by a collective desire for enhanced health outcomes through natural means.

Restraints in the Global Probiotics In Human Nutrition Market

The Global Probiotics in Human Nutrition market faces challenges stemming from significant investments required for research and development activities, which include setting up laboratories, acquiring research equipment, and recruiting skilled personnel. While scientific validation of probiotics' health benefits supports market growth, manufacturers often struggle to achieve a satisfactory return on these substantial initial expenses. These high costs can deter new entrants and limit expansion opportunities for existing businesses, creating an environment where innovation may be stifled and growth potential compromised. As a result, balancing research expenditures with profitability remains a critical concern for stakeholders in this burgeoning market.

Market Trends of the Global Probiotics In Human Nutrition Market

The Global Probiotics in Human Nutrition market is witnessing a robust trend towards innovation and diversification, with manufacturers expanding their product lines to include a variety of probiotic formats such as pills, drops, and capsules tailored to specific health needs. As consumer awareness of gut health and its connection to overall wellness continues to rise, both private label and branded companies are proactively introducing novel formulations featuring distinct probiotic strains. This growth trajectory is driven by the increasing demand for personalized nutrition solutions, setting the stage for a dynamic marketplace that prioritizes efficacy and consumer choice in the realm of dietary supplementation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Probiotics In Human Nutrition Market Size by Type & CAGR (2026-2033)

• Market Overview
• Lactobacillus
• Bifidobacterium
• Saccharomyces
• Streptococcus
• Enterococcus
• Escherichia
• Bacillus

Global Probiotics In Human Nutrition Market Size by Application & CAGR (2026-2033)

• Market Overview
• Dietary Supplements
• Functional Nutrition
• Sports Nutrition
• Infant Nutrition
• Other Applications

Global Probiotics In Human Nutrition Market Size & CAGR (2026-2033)

• North America (Type, Application)
  • US
  • Canada
• Europe (Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Danone S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yakult Honsha Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chr. Hansen Holding A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Flavors & Fragrances Inc. (IFF) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company (ADM) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Probi AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGaia AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morinaga Milk Industry Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifeway Foods, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Mills, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PepsiCo, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UAS Laboratories LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Winclove Probiotics B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM-Firmenich (Netherlands/Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Protexin (UK) (part of ADM)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bifodan A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations